N. Nakamura
4 Papers
7 Citations
N. Nakamura is an academic researcher. The author has contributed to research in topics: CD34 & Haematopoiesis. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Update of YOKOHAMA HTS Cable Project
Hiroyasu Yumura,Yuichi Ashibe,M. Ohya,H. Itoh,M. Watanabe,T. Masuda,Hiroshi Ichikawa,Tomoo Mimura,S. Honjo,Tsukushi Hara,R. Ohno,M. Shimoda,N. Nakamura,T. Komagome,H. Yaguchi +14 more
TL;DR: In this article, the high-temperature superconducting (HTS) cable demonstration project supported by Ministry of Economy, Trade and Industry and New Energy and Industrial Technology Development Organization has started in Japan and the target of this project is to operate a 66 kV, 200 MVA HTS cable in the live network of Tokyo Electric Power Company in order to demonstrate its reliability and stable operation.
65
Results of Japan's First In-Grid Operation of 200-MVA Superconducting Cable System
O. Maruyama,S. Honjo,Tetsutaro Nakano,T. Masuda,M. Watanabe,M. Ohya,H. Yaguchi,N. Nakamura,A. Machida +8 more
TL;DR: In this article, a high-temperature superconducting (HTS) power cable demonstration project was started in 2007 to evaluate the cable's performance, stability, and reliability This project aims to operate a 66-kV 200-MVA HTS cable system in a real power grid of the Tokyo Electric Power Company.
27
In-grid Demonstration of High-temperature Superconducting Cable
M. Ohya,Yuuichi Ashibe,Michihiko Watanabe,Hiroyasu Yumura,T. Nakanishi,H. Hirota,T. Masuda,R. Ono,M. Shimoda,N. Nakamura,T. Komagome,H. Yaguchi,M. Ikeuchi,A. Machida,Hiroshi Ichikawa,Tomoo Mimura,Shoichi Honjo,Tsukushi Hara +17 more
TL;DR: In this paper, the first in-grid demonstration of a high-temperature superconducting (HTS) cable system in Japan was carried out to verify its reliability and stable operation.
7
Post-azacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms
Yasuhito Nannya,Magnus Tobiasson,S. Sato,Elsa Bernard,Shimon Ohtake,June Takeda,Maria Creignou,Manabu Kusakabe,Yuhei Shibata,N. Nakamura,M. Watanabe,Nobuhiro Hiramoto,Yusuke Shiozawa,Yuichi Shiraishi,H. Tanaka,K. Yoshida,Hideki Makishima,Masahiro Nakagawa,Katsutoshi Usuki,Kenjiro Imada,Hiroshi Handa,Masao Taguchi,Toru Kiguchi,Kazuma Ohyashiki,T. Ishikawa,Akifumi Takaori,Hanako Tsurumi,Senji Kasahara,S. Chiba,Tetsuro Naoe,S. Miyano,Elli Papaemmanuil,Yasushi Miyazaki,Eva Hellström-Lindberg,S. Ogawa +34 more
TL;DR: In this article , a straightforward experimental strategy was proposed to test the potential of a novel gene therapy vector for X-linked chronic granulomatous disease (X-CGD), a severe primary immunodeficiency caused by mutations in the gp91phox subunit of the phagocytic NADPH oxidase.